Cullinan Therapeutics, Inc.盘中异动下午盘股价大跌5.12%

市场透视2025-05-15

北京时间2025年05月15日02时26分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现异动，股价快速下跌5.12%。截至发稿，该股报7.23美元/股，成交量13.2491万股，换手率0.22%，振幅7.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.61倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535900948?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 02:26","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535900948","market":"us","top_or_hot":-1,"title":"Cullinan Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月15日02时26分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现异动，股价快速下跌5.12%。截至发稿，该股报7.23美元/股，成交量13.2491万股，换手率0.22%，振幅7.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.61倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502265994f6fc4d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cullinan Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCullinan Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 02:26 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502265994f6fc4d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月15日02时26分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现异动，股价快速下跌5.12%。截至发稿，该股报7.23美元/股，成交量13.2491万股，换手率0.22%，振幅7.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.61倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502265994f6fc4d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502265994f6fc4d&s=b","article_id":"2535900948","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051502265994f6fc4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535900948","pubTimestamp":1747247219,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月15日02时26分，Cullinan Therapeutics, Inc.股票出现异动，股价快速下跌5.12%。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc 是一家生物制药公司。该信息摘要如下：瑞银：维持Cullinan Therapeutics评级，由买入调整至买入评级, 目标价由30.00美元调整至24.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","CGEM":"Cullinan Therapeutics","BK4139":"生物科技","BK4007":"制药","BK4539":"次新股"},"translate_title":"Cullinan Therapeutics, Inc. shares tumbled 5.12% in afternoon trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"CGEM":1},"content_text":"北京时间2025年05月15日02时26分，Cullinan Therapeutics, Inc.（CGEM.us）股票出现异动，股价快速下跌5.12%。截至发稿，该股报7.23美元/股，成交量13.2491万股，换手率0.22%，振幅7.09%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-48.50百万美元，每股收益-0.82美元，毛利-76000.00美元，市盈率-2.61倍。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cullinan Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。其相关个股中，Klotho Neurosciences, Inc.、Onconetix, Inc.、蓝鸟生物涨幅较大，Polyrizon Ltd.、Nucana Plc、Klotho Neurosciences, Inc.较为活跃，换手率分别为4850.35%、4612.79%、1726.01%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 (To Pur Com)、Onconetix, Inc.，振幅分别为339.54%、202.60%、135.53%。Cullinan Therapeutics, Inc.公司简介：Cullinan Therapeutics Inc 是一家生物制药公司。它拥有多元化的临床阶段资产组合，可抑制疾病的关键驱动因素或利用免疫系统来消除肿瘤和自身免疫性疾病中的病变细胞。它对肿瘤学、免疫学和转化医学的理解创造了差异化的想法，确定了合适的目标，并选择了最佳模式来开发针对各种癌症和自身免疫适应症的变革性疗法。它有一个报告部门和一个运营部门，即开发免疫学和肿瘤疗法的业务。消息层面，截至02时26分，《瑞银：维持Cullinan Therapeutics评级，由买入调整至买入评级, 目标价由30.00美元调整至24.00美元。》资讯为影响Cullinan Therapeutics, Inc.的重要信息。该信息摘要如下：瑞银：维持Cullinan Therapeutics(CGEM.US)评级，由买入调整至买入评级, 目标价由30.00美元调整至24.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535900948","isCrawlerRequest":true}

Cullinan Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%

精彩评论

Cullinan Therapeutics, Inc.盘中异动下午盘股价大跌5.12%